News

Former Aetna Executive, Nancy Cocozza, Joins Real Time Medical Systems as New Senior Health Plan Advisor

A highly esteemed leader within the healthcare industry, Cocozza will help advance Real Time solutions to the payer market, to…

2 years ago

Carium Welcomes Rich Steinle as CEO

As CEO, Steinle will lead Carium through its next phase of growth in virtual care tech PETALUMA, Calif., June 15,…

2 years ago

Innovation Pharmaceuticals Acquires Stake in Squalus Medical, Seeks to Reshape Cancer and Epilepsy Treatments Through a New Image Guided Laser-Based Ablation Technology

Innovation Pharmaceuticals acquires a minority ownershipSqualus has invented and is developing a leading-edge image guided surgical laser platform for treating…

2 years ago

NuGen M.D. Submits for FDA Emergency Use Authorization Approval for its Needle-Free Injection Systems

VANCOUVER, BC / ACCESSWIRE / June 15, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) ("NuGen'' or the "Company"), a leader…

2 years ago

Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022

REDWOOD CITY, CA / ACCESSWIRE / June 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…

2 years ago

AGS Health Announces New Location in Jaipur, India

Amid rapid growth, AGS Health, a global leader in revenue cycle management solutions, establishes operations in Jaipur, IndiaWASHINGTON, DC /…

2 years ago

Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared

ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

2 years ago

Forza Innovations Inc. Announces $480,000 Financing Agreement

SAN DIEGO, CA, June 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forza Innovations Inc.  (OTC Pink: FORZ) (the “Company”)…

2 years ago

Renibus Therapeutics Announces Positive Interim Data from RBT-1 Phase 2 Trial

RBT-1 met primary endpoint of increasing the expression of biomarkers of cytoprotective preconditioning; positive data supports the potential for RBT-1…

2 years ago

Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR

SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk…

2 years ago